New York Times Takes European Commission to Court Over Covid Vaccine Deal

Published On Nov 15, 2024, 5:25 AM

The New York Times has initiated a lawsuit against the European Commission to obtain text messages exchanged between the Commission's president, Ursula von der Leyen, and Pfizer's CEO, Albert Bourla. These messages were related to the negotiation of a significant COVID-19 vaccine contract. The case raises important questions about transparency in government dealings and could set a precedent regarding what constitutes an official document within the European Union. The European Commission claims no such messages exist or were needed to be registered, characterizing them as ephemeral and not official records.

Read full article

Stock Forecasts

PFEView PFE chart on TradingView

Negative

With ongoing scrutiny regarding vaccine agreements and transparency, Pfizer (PFE) could face reputational risks if it is found that there were undisclosed negotiations. The potential fallout could negatively impact investor confidence and share prices, particularly as legal proceedings may attract media attention and public scrutiny.

Related News

Robert F. Kennedy Jr.’s FDA Wish List: Raw Milk, Stem Cells, Heavy Metals

Nov 12, 2024, 9:44 AM

Robert F. Kennedy Jr., one of President-elect Donald J. Trump’s advisers on health, is taking aim at the agency’s oversight on many fronts.

PFE

Wall Street expects Trump presidency will unlock deal-making

Nov 7, 2024, 11:00 AM

Deal-making has slowed in recent years, largely due to high interest rates, soaring company valuations and a tight regulatory environment.

KR
PFE
XLF

Why Businesses Worry About R.F.K. Jr.

Nov 1, 2024, 8:01 AM

The Kennedy scion has long been a skeptic of vaccines, pesticides and more. Corporate leaders worry he may gain policy power if Donald Trump wins.

PFE
CORN